GNC releases clinical results of neuromuscular fatigue treatment

LAS VEGAS GNC on Monday released clinical results for its nitric oxide product Amplified Maxertion N.O. — demonstrating a delay in the onset of neuromuscular fatigue — at the National Strength and Conditioning Association conference.

GNC's Amplified Maxertion N.O. was shown to increase power output at the onset of neuromuscular fatigue by an average of 20% and improve physical performance by helping athletes push past their normal point of exhaustion.

"This is truly groundbreaking research that has resulted in the delivery of a truly novel and clinically-validated [sports nutrition] product to the industry," stated Guru Ramanathan, SVP technology and product innovation for GNC. "Using advanced technology and ingredients, this is the first nitric oxide enhancing product to demonstrate significant athletic performance effects that are relevant and meaningful to all types of athletes."

Amplified Maxertion N.O. is part of a comprehensive line of eight new advanced muscle performance and sports nutrition products from GNC. The entire Pro Performance AMP line was designed to suit the needs of a wide range of dedicated athletes, from the weekend warrior to the ultra competitive athlete.